Beginning Cash: The amount of cash reported by the company on its previous statement.
Addex Therapeutics Ltd. Sponsored ADR (ADXN) had Beginning Cash of $4.03M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.04M |
|
$-8.12M |
|
-- |
|
$0.04M |
|
$3.43M |
|
$-3.40M |
|
$-4.86M |
|
$-8.26M |
|
$-8.26M |
|
$-8.26M |
|
$-8.26M |
|
$-8.12M |
|
$-8.26M |
|
$-3.40M |
|
$-3.39M |
|
0.89M |
|
0.89M |
|
$-8.69 |
|
$-8.69 |
|
| Balance Sheet Financials | |
$2.03M |
|
$0.00M |
|
$5.65M |
|
$7.68M |
|
$1.45M |
|
-- |
|
$0.48M |
|
$1.93M |
|
$5.75M |
|
$5.75M |
|
$5.75M |
|
0.98M |
|
| Cash Flow Statement Financials | |
$-2.62M |
|
$-0.82M |
|
$1.43M |
|
|
Beginning Cash |
$4.03M |
$1.98M |
|
$-2.06M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-9390.76% |
|
-9390.76% |
|
-9362.49% |
|
-22829.94% |
|
-22448.44% |
|
$-2.62M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.49 |
|
244.62 |
|
-143.55% |
|
-143.55% |
|
-107.52% |
|
-143.55% |
|
$5.85 |
|
$-2.93 |
|
$-2.93 |
|